Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer.
Shi X, Li H, Shi A, Yao H, Ke K, Dong C, Zhu Y, Qin Y, Ding Y, He YH, Liu X, Li L, Lei L, Hai Q, Chen W, Leung KS, Wong MH, Kung HF, Lin MC.
Shi X, et al. Among authors: yao h.
Oncol Rep. 2018 Sep;40(3):1592-1600. doi: 10.3892/or.2018.6533. Epub 2018 Jun 27.
Oncol Rep. 2018.
PMID: 29956794